IT1200080B - SOLID DISPERSION OF A PHARMACEUTICALLY ACTIVE AGENT, PARTICULARLY DIHYDROPYRIDINE, IN A WATER SOLUBLE CRYSTALLINE MATRIX, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PROCESS FOR THEIR PREPARATION - Google Patents

SOLID DISPERSION OF A PHARMACEUTICALLY ACTIVE AGENT, PARTICULARLY DIHYDROPYRIDINE, IN A WATER SOLUBLE CRYSTALLINE MATRIX, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PROCESS FOR THEIR PREPARATION

Info

Publication number
IT1200080B
IT1200080B IT8548210A IT4821085A IT1200080B IT 1200080 B IT1200080 B IT 1200080B IT 8548210 A IT8548210 A IT 8548210A IT 4821085 A IT4821085 A IT 4821085A IT 1200080 B IT1200080 B IT 1200080B
Authority
IT
Italy
Prior art keywords
preparation
pharmaceutical composition
active agent
composition containing
water soluble
Prior art date
Application number
IT8548210A
Other languages
Italian (it)
Other versions
IT8548210A0 (en
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8548210A0 publication Critical patent/IT8548210A0/en
Application granted granted Critical
Publication of IT1200080B publication Critical patent/IT1200080B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT8548210A 1984-06-14 1985-06-13 SOLID DISPERSION OF A PHARMACEUTICALLY ACTIVE AGENT, PARTICULARLY DIHYDROPYRIDINE, IN A WATER SOLUBLE CRYSTALLINE MATRIX, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PROCESS FOR THEIR PREPARATION IT1200080B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (2)

Publication Number Publication Date
IT8548210A0 IT8548210A0 (en) 1985-06-13
IT1200080B true IT1200080B (en) 1989-01-05

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8548210A IT1200080B (en) 1984-06-14 1985-06-13 SOLID DISPERSION OF A PHARMACEUTICALLY ACTIVE AGENT, PARTICULARLY DIHYDROPYRIDINE, IN A WATER SOLUBLE CRYSTALLINE MATRIX, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PROCESS FOR THEIR PREPARATION

Country Status (21)

Country Link
AT (1) AT391806B (en)
AU (2) AU587190B2 (en)
BE (1) BE902626A (en)
CA (1) CA1264441A (en)
CY (1) CY1635A (en)
DE (1) DE3520184C2 (en)
DK (1) DK167649B1 (en)
ES (1) ES8702141A1 (en)
FR (1) FR2565822B1 (en)
GB (3) GB2160100B (en)
GR (1) GR851430B (en)
HK (1) HK25192A (en)
HU (1) HU198844B (en)
IE (1) IE58834B1 (en)
IL (1) IL75490A0 (en)
IT (1) IT1200080B (en)
LU (1) LU85946A1 (en)
NL (1) NL194389C (en)
NZ (1) NZ212390A (en)
PT (1) PT80635B (en)
SE (1) SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (en) * 1985-10-15 1987-12-23 Eurand Spa PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0406315B1 (en) * 1988-03-24 1992-11-11 Bukh Meditec A/S Controlled release composition
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
DK469989D0 (en) * 1989-09-22 1989-09-22 Bukh Meditec PHARMACEUTICAL PREPARATION
MX9300110A (en) * 1992-01-13 1994-07-29 Gerhard Gergely PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
US6093420A (en) 1996-07-08 2000-07-25 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
DE19710009A1 (en) * 1997-03-12 1998-09-24 Knoll Ag Multi-phase preparation forms containing active ingredients
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
WO2000076480A2 (en) * 1999-06-11 2000-12-21 Eli Lilly And Company Pharmaceutical materials and methods for their preparation and use
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
ATE324909T1 (en) * 1999-08-04 2006-06-15 Astellas Pharma Inc STABLE MEDICAL COMPOSITIONS FOR ORAL ADMINISTRATION USING IRON OXIDES
JP3893058B2 (en) 1999-09-30 2007-03-14 ペンウェスト ファーマシューティカルズ カンパニー Sustained release matrix system for highly soluble drugs
EP1368006B1 (en) * 2001-02-13 2006-05-03 AstraZeneca AB Novel modified released formulation
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
CA2670749A1 (en) 2006-12-05 2008-06-12 Landec Corporation Drug delivery
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
CN102271661A (en) * 2008-08-20 2011-12-07 德克萨斯州立大学董事会 Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (en) * 1967-11-17 1971-03-25 Beiersdorf Ag Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) * 1975-11-17 1978-03-22 Sandoz Ltd Tablet formulations
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DK149855C (en) * 1977-06-20 1987-04-21 Sandoz Ag METHOD OF ANALOGY FOR THE PREPARATION OF 1,4-DIHYDROPYRIDINE DERIVATIVES
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DK154607C (en) * 1978-12-21 1989-06-05 Sandoz Ag PROCEDURE FOR PREPARING A PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ERGOTAL KALOIDS
DE2904310A1 (en) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (en) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
EP0078430B2 (en) * 1981-10-29 1993-02-10 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
DE3318649A1 (en) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen TWO-PHASE FORMULATION

Also Published As

Publication number Publication date
GR851430B (en) 1985-11-25
IT8548210A0 (en) 1985-06-13
AT391806B (en) 1990-12-10
IE58834B1 (en) 1993-11-17
GB2196851A (en) 1988-05-11
DK264785D0 (en) 1985-06-12
GB2196852B (en) 1989-05-17
CY1635A (en) 1992-11-06
ES8702141A1 (en) 1987-01-01
AU4454389A (en) 1990-03-22
CA1264441A (en) 1990-01-16
GB8727055D0 (en) 1987-12-23
GB2196851B (en) 1989-06-07
HU198844B (en) 1989-12-28
HK25192A (en) 1992-04-10
SE8502950D0 (en) 1985-06-13
FR2565822B1 (en) 1989-02-17
ATA174885A (en) 1990-06-15
DE3520184C2 (en) 1997-03-13
GB2196852A (en) 1988-05-11
IE851460L (en) 1985-12-14
LU85946A1 (en) 1986-01-24
NL194389B (en) 2001-11-01
IL75490A0 (en) 1985-10-31
DK167649B1 (en) 1993-12-06
ES544075A0 (en) 1987-01-01
SE8502950L (en) 1985-12-15
SE504583C2 (en) 1997-03-10
PT80635A (en) 1985-07-01
GB2160100A (en) 1985-12-18
GB8514855D0 (en) 1985-07-17
AU4348685A (en) 1985-12-19
BE902626A (en) 1985-12-10
NZ212390A (en) 1992-02-25
NL8501578A (en) 1986-01-02
DE3520184A1 (en) 1985-12-19
AU587190B2 (en) 1989-08-10
GB8727056D0 (en) 1987-12-23
DK264785A (en) 1985-12-15
HUT40918A (en) 1987-03-30
GB2160100B (en) 1989-06-01
FR2565822A1 (en) 1985-12-20
NL194389C (en) 2002-03-04
PT80635B (en) 1987-10-20

Similar Documents

Publication Publication Date Title
IT1200080B (en) SOLID DISPERSION OF A PHARMACEUTICALLY ACTIVE AGENT, PARTICULARLY DIHYDROPYRIDINE, IN A WATER SOLUBLE CRYSTALLINE MATRIX, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PROCESS FOR THEIR PREPARATION
IT8547844A1 (en) TABLETS OF PHARMACEUTICAL ACTIVE SUBSTANCE THAT DESRINES RAPIDLY STABLE IN STORAGE
IE880281L (en) Swellable pellets
IT9067443A0 (en) PROCEDURE FOR FORMING A POROUS REFRACTORY MASS AND COMPOSITION OF MATERIAL TO BE USED IN THIS PROCEDURE.
IT1176613B (en) PHARMACOLOGICALLY ACTIVE PIPERAZINIC DERIVATIVES AND PROCESS FOR THEIR PREPARATION
IE873213L (en) Galenical Formulation
IT1243357B (en) METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION IN THE FORM OF MICROPARTICLES
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
FR2624863B1 (en) NOVEL CRYSTALLINE FORM OF CICLOSPORIN, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
IL114335A (en) Pharmacologically active CNS compounds process for their preparation and pharmaceutical compositions containing them
DK455286A (en) PHARMACEUTICAL AGENT WITH SLOW RELEASE AND PROCEDURE FOR ITS PREPARATION
NO175894C (en) Crystalline (metallo) silicates and germanates, SUZ-2, process for their preparation and use thereof
EE04238B1 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives, process for their preparation, pharmaceutical compositions containing said therapeutically active substances and use of said active compounds in therapy
HUT48609A (en) Process for producing kumaran derivatives and pharmaceutical compositions comprising same as active ingredient
HUT48269A (en) Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them
RU93036959A (en) FREE SOLUBLE MEDICATION WITH SLOW-UP ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES, ASSIGNED FOR RECEPTION INSIDE, THE METHOD OF ITS MANUFACTURE
PT90466A (en) PREPARATION PROCESS OF PHARMACEUTICAL COMPOSITIONS COMPOSING AN EXTRAGRANULAR EXCIPIENT, INSOLUBLE HYGROSCOPE IN WATER AND AN ACTIVE INGREDIENT, IN PARTICULAR CIMETIDINE
IT8812585A0 (en) PREPARATION, IN PARTICULAR ANTI-SUN COSMETIC PREPARATION, AS WELL AS A METHOD FOR INTRODUCING AN ACTIVE SUBSTANCE INTO THE SKIN
LV5765A4 (en) Method for obtaining (S) - (-) - 1-propyl-2 ', 6'-pipecoloxylid hydrochloride monohydrate and its pharmaceutical preparation
ZA848140B (en) New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions
KR900700452A (en) Tetrahydropyridine derivatives, pharmaceutical composition containing same and manufacturing method thereof
NO985807D0 (en) Transdermal systems containing 2 active ingredients in separate sections, their preparation process and their use as a drug
EP0310126A3 (en) Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
AR244243A1 (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
HUT39439A (en) Process for producing new thiazolidinedione derivatives and pharmaceutical compositions containing them as active agents

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970623